PADI4 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated

Peptidylarginine deiminase type4 (PADI4) was firstly identified as a non-MHC RA genetic risk factor. Furthermore, PADI4 risk allele possessed the association with bone damage regardless of anti citrullinated peptide antibody (ACPA) positivity in Asian RA patients. PADI4 gene codes PAD4 protein which has post-translational modification activity (citrullination). Padi4 is mainly expressed in myeloid cells and granulocytes. PADI4 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated is expressed in E. coli expression system with N-His tag. The predicted molecular weight is 76.6 kDa and the accession number is Q9UM07.

规格	价格/CNY		数量
100 μg	￥ 6,670	5日内发货
500 μg	￥ 26,700	5日内发货
1 mg	￥ 44,500	5日内发货

规格

价格/CNY

货期

数量

100 μg

￥ 6,670

5日内发货

500 μg

￥ 26,700

5日内发货

1 mg

￥ 44,500

5日内发货

产品描述

种属	Human
表达系统	E. coli
标签	N-His
蛋白编号	Q9UM07
别名	PDI5, Protein-arginine deiminase type-4, HL-60, PAD4, HL-60 PAD, PAD, HL60 PAD, PADI5
蛋白构建	Met1-Pro663
蛋白纯度	> 95% as determined by Tris-Bis PAGE
分子量	76.6 kDa (predicted) same as Tris-Bis PAGE result.

内毒素	< 1 EU/μg by the LAL method.
缓冲液	Supplied as 0.22 μm filtered solution in LTSB.
存储	It is recommended to store the product under sterile conditions at -70℃ or lower. Samples are stable for up to 12 months at -80℃. Please avoid multiple freeze-thaw cycles and store products in aliquots.
运输方式	In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
研究背景	Peptidylarginine deiminase type4 (PADI4) was firstly identified as a non-MHC RA genetic risk factor. Furthermore, PADI4 risk allele possessed the association with bone damage regardless of anti citrullinated peptide antibody (ACPA) positivity in Asian RA patients. PADI4 gene codes PAD4 protein which has post-translational modification activity (citrullination). Padi4 is mainly expressed in myeloid cells and granulocytes.